Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy Noboru Kitamura , Hitomi Kobayashi , Yosuke Nagasawa , Kaita Sugiyama , Hiroshi Tsuzuki , Yutaka Tanikawa , Natsumi Ikumi , Yuito Okada , Yasuo Takahashi , Satoshi Asai , Naoto Tamura , Michihiro Ogasawara , Toshio Kawamoto , Ryohei Kuwatsuru , Hiromichi Tamaki , Genki Kidoguchi , Mutsuto Tateishi , Makiko Kimura , Yuichi Mochida , Kengo Harigane , Takayuki Shimazaki , Takao Koike , Kazuhide Tanimura , Hiroshi Kataoka , Koichi Amano , Hidekata Yasuoka , Masami Takei International journal of rheumatic diseases(2023)
关键词
anti-tumor necrosis factor, golimumab, methotrexate, relapse, rheumatoid arthritis
AI 理解论文
溯源树
样例